Cara Therapeutics | CARA - Trade Creditors

Stock Price
4.18
Daily Change
-0.03 -0.71%
Monthly
41.22%
Yearly
-83.68%
Q2 Forecast
3.07

Cara Therapeutics reported $3.22M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 12.25M 1.34M Mar/2026
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Assertio Holdings USD 14.66M 3.81M Sep/2025
Cara Therapeutics USD 3.22M 859K Dec/2025
Cassava Sciences USD 41.65M 4.44M Dec/2025
Chugai Pharma JPY 107.52B 19.72B Mar/2026
Cipla INR 30.35B 1.98B Sep/2025
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.35M 6.77M Dec/2025
CSL USD 3.17B 290M Dec/2025
Grifols EUR 987.75M 47.87M Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
J&J USD 10.46B 1.53B Mar/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Pacira USD 14.01M 1.14M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
RedHill Biopharma USD 835K 7.03M Jun/2025
Supernus Pharmaceuticals USD 10.17M 97.63M Mar/2026
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024